First autonomous, entirely soft robot (Image 1)
This robot, dubbed the "octobot," is the world?s first robot comprised entirely of soft materials. Unlike traditional robots, this prototype, developed by researchers at Harvard University, does not need batteries or electronics to operate. One day, more sophisticated, entirely soft robots like ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - December 14, 2016 Category: Science Source Type: video
First autonomous, entirely soft robot (Image 2)
This robot, dubbed the "octobot," is the world?s first robot comprised entirely of soft materials. Unlike traditional robots, this prototype, developed by researchers at Harvard University, does not need batteries or electronics to operate. One day, more sophisticated, entirely soft robots like ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - December 14, 2016 Category: Science Source Type: video
First autonomous, entirely soft robot (Image 3)
This robot, dubbed the "octobot," is the world?s first robot comprised entirely of soft materials. Unlike traditional robots, this prototype, developed by researchers at Harvard University, does not need batteries or electronics to operate. One day, more sophisticated, entirely soft robots like ...This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - December 14, 2016 Category: Science Source Type: video
The Dana-Farber Cancer Institute Quality and Safety Journey: A Long and Winding Road
NCI ’ s Center for Cancer Research (CCR) Grand Rounds
Dr. Craig Bunnell received his MD from Harvard Medical School and his MPH from Harvard School of Public Health in 1990. He received his MBA from the Massachusetts Institute of Technology in 2008. He completed his residency in internal medicine and a fellowship in hematology and oncology at Brigham and Women's Hospital, where he also served as chief medical resident. He joined Dana-Farber in 1996, and is a member of the Breast Oncology Center in the Susan F. Smith Center for Women's Cancers. Dr. Bunnell was named Dana-Farber's Chief Medical Officer in 2012.
Dr. Anne Gr...
Source: Videocast - All Events - November 28, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
How to Hit HIV Where It Hurts
Immunology Interest Group Seminar Series
No medical procedure has saved more lives than vaccination. But, today, some pathogens have evolved which have defied successful vaccination using the empirical paradigms pioneered by Pasteur and Jenner. One characteristic of many pathogens for which successful vaccines do not exist is that they present themselves in various guises. HIV is an extreme example because of its high mutability. This highly mutable virus can evade natural or vaccine induced immune responses, often by mutating at multiple sites linked by compensatory interactions. I will first describe how by bringing to t...
Source: Videocast - All Events - November 10, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Stressed out: a novel approach to cancer immunotherapy
NIH Director's Wednesday Afternoon Lecture
Inaugural William Paul Lecture
Dr. Glimcher is president and CEO of Dana-Farber Cancer Institute in Boston and a former dean of Weill Cornell Medical College in New York City. Prior to her work at Cornell, Dr. Glimcher was a professor of medicine at Harvard Medical School, where she headed one of the top immunology programs in the world. As an immunologist, her primary research interests are elucidating the molecular pathways that regulate the immune system, critical for both the development of protective immunity and for the pathophysiologic immune responses underlying autoimmune...
Source: Videocast - All Events - November 7, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
MPS Distinguished Lecture by Professor Al?n Aspuru-Guzik, Harvard University
NSF Distinguished Lecture Series in Mathematical and Physical Sciences: Professor Al?n Aspuru-Guzik from Harvard University, on October 13, 2016.
Title: Billions and Billions of Molecules: Exploring Molecular Space with Classical and
Quantum Computers
Original air date: October 13, 2016This is an NSF Multimedia Gallery item. (Source: NSF Multimedia Gallery)
Source: NSF Multimedia Gallery - October 28, 2016 Category: Science Source Type: video
NIH Challenge Symposium 2016
The Office of the Associate Director for Data Science (ADDS Office) is pleased to announce a Challenge Symposium to explore the use of challenges as a mechanism for achieving scientific goals. The symposium will start with remarks from Tom Kalil, Deputy Director for Policy at the White House Office of Science and Technology Policy. Next, Dr. Karim Lakhani, a Harvard Business School professor who does research on challenges and innovation, will give a lecture as part of the Frontiers in Data Science series. The symposium will conclude with a panel discussion.
1:30 Introductions1:35 – 2:00 View from the White House, Tom ...
Source: Videocast - All Events - September 6, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
" Minding " your balance with Tai Chi: The Interdependence of Cognitive and Motor Function in the Elderly
The National Center for Complementary and Integrative Health (NCCIH) presents the Integrative Medicine Research Lecture Series. The series provides overviews of the current state of research and practice involving complementary health approaches and explores perspectives on the emerging discipline of integrative medicine. Dr. Peter Wayne is an Assistant Professor of Medicine, Harvard Medical School, and Director of Research, Osher Center for Integrative Medicine, Dvision of Preventive Medicine at Brigham and Women's Hospital and Harvard Medical School. Dr. Wayne's will summarize the state of clinical research evidence for ...
Source: Videocast - All Events - August 19, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Imaging Chemokine Function in Disease
Immunology Interest Group
Dr. Luster studied medicine at Cornell University Medical College and obtained a Ph.D. degree under mentorship of Drs. Jeffrey Ravetch and Zanvil Cohn at the Rockefeller University. As a graduate student, he discovered and characterized the IFN-gamma-inducible protein 10 (IP-10/CXCL10) (Nature 1985; 315:672-676)! He completed residency and a clinical fellowship in medicine and infectious diseases at Massachusetts General Hospital and post-doctoral training in the laboratory of Dr. Philip Leder at Harvard Medical School. In 1994, he joined the faculty of Harvard Medical School and Massachusetts Ge...
Source: Videocast - All Events - June 15, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
DDM Seminar: The Puzzle of Motivation
DDM Seminar Series
The fourth and final installment of the FY2016 DDM Seminar Series. To receive credit for watching the LIVE Videocast, you need to register for the event in LMS on the morning of the event. Archived Videocast registration is also available in LMS approximately 10 days after the event. Video cast from Masur Auditorium, our featured speaker Daniel Pink looks at the conundrum of motivation through the lenses of scientific and business practices. Daniel H. Pink is the author of five provocative books about business, work, and behavior – including three long-running New York Times bestsellers, A Whole New M...
Source: Videocast - All Events - June 10, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Innate Immune Mechanism for Viral dsRNA Detection – RIG-I-like Receptors
Immunology Interest Group
Dr. Hur received her B.S. in physics from Ewha Women’s University in Korea in 2001, her Ph.D. in physical chemistry with Dr. Thomas C. Bruice at the University of California, Santa Barbara in 2003 and then did her post-doctoral work in X-ray crystallography with Dr. Robert M. Stroud at the University of California, San Francisco. Dr. Hur joined Harvard Medical School in 2008 as an assistant professor in the Department of Biological Chemistry and Molecular Pharmacology. In 2014, she was promoted to an associate professor with a joint appointment at Boston Children’s Hospital. Dr. Hur is a reci...
Source: Videocast - All Events - May 26, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
New Insights into Flavivirus Pathogenesis and Immunity: Yes, that Includes Zika Virus.
Dr. Michael Diamond received a B.A. degree in political science at Columbia University before pursuing medical and graduate training at Harvard School of Medicine. As a graduate student, he investigated the regulation of the integrin Mac-1 (CD11b/CD18) in the laboratory of Dr. Timothy Springer. He did a residency and a clinical fellowship in infectious diseases at the University of California, San Francisco, and most of his post-doctoral training in the laboratory of Dr. Eva Harris at the University of California, Berkeley. He was recruited to Washington University in St. Louis as an Assistant Professor in 2001 and is now ...
Source: Videocast - All Events - May 20, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Hijacking the Hematopoietic System and Other Dirty Tricks that Breast Cancers Play
NCI’s Center for Cancer Research (CCR) Grand Rounds
Dr. McAllister is an Associate Scientist in the Hematology Division at Brigham & Women’s Hospital and an Assistant Professor of Medicine at Harvard Medical School in Boston. She received her undergraduate degree at the University of Michigan in Ann Arbor and completed her Ph.D. studies in molecular and cellular biology at Washington University School of Medicine in St. Louis. She joined Robert Weinberg’s laboratory at the Whitehead Institute for Biomedical Research as a postdoctoral fellow where she established new pre-clinical models to study breast cancer pa...
Source: Videocast - All Events - May 9, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
Why do most patients with epithelial cancers not respond to T cell checkpoint blockade?
NCI Center for Cancer Research Eminent Lecture
Over the past 40 years, Dr. Fearon has made contributions to our understanding of innate immunity, B cell signal transduction, memory T cells, and, most recently, cancer immunology. During the past 10 years, Dr. Fearon has trained 15 PhD and MB/PhD students at the University of Cambridge. Former post-doctoral fellows now have faculty or staff positions at outstanding institutions such as Harvard Medical School, the NIAID, University of Cambridge, King’s College London, University of Leicester, and the University of Ryukyus. His past work with a genetically engineered mous...
Source: Videocast - All Events - April 20, 2016 Category: Journals (General) Tags: Upcoming Events Source Type: video
